Recent studies have shown that the percentage of CD44 positive cells expressing variant exons v6 (CD44v6) in tumor cells could be significantly increased by HIF-1α-mediated transcription under hypoxic conditions [28]. This evidence concerns the gene CD44 and neoplasm.